Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodGilead Sciences reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 13 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Budget/Appropriations8/8
- Copyright/Patent/Trademark8/8
- Health Issues8/8
- Medicare/Medicaid8/8
- Taxation/Internal Revenue Code8/8
Trade (domestic/foreign) 8 of 8 · Pharmacy 7 of 8 · Show all 7
- Trade (domestic/foreign)8/8
- Pharmacy7/8
Bills named in the filings 16 bills, this period
- H.R. 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.9 filings
- H.R. 5376 Impacts and Outcomes for Health Career Training Act Broad bill7 filings
- S. 998 / H.R. 2213 Medical Supply Chain Resiliency Act4 filings
- H.R. 4299 Protecting Patient Access to Cancer and Complex Therapies Act3 filings
- S. 839 Safeguarding Honest Speech Act2 filings
11 more, 10 named in only one filing · Show all 16
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill2 filings
- H.R. 3290, 118th 340B Transparency Act1 filing
- H.R. 5391, 118th Protecting Patient Access to Cancer and Complex Therapies Act1 filing
- S. 2764, 118th Protecting Patient Access to Cancer and Complex Therapies Act of 20231 filing
- S. 3131 / H.R. 5539, 118th ORPHAN Cures Act1 filing
- S. 476 / H.R. 5547, 118th Maintaining Investments in New Innovation Act1 filing
- S. 832 EPIC Act of 20251 filing
- H.R. 10445, 118th Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 Broad bill1 filing
- H.R. 10545, 118th American Relief Act, 2025 Broad bill1 filing
- H.R. 5376, 118th Share the Savings with Seniors Act Broad bill1 filing
- H.R. 5378, 118th Lower Costs, More Transparency Act Broad bill1 filing
From the filings
“Implementation H.R.5376 - Inflation Reduction Act of 2022. Issues around drug pricing.”
“Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries.”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CDC
- CMS
- DOC
- FDA
- HHS
- NIH
- PTO
- DOS
- Treasury
- USTR
- 5 more
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Gilead Sciences, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 148 sitting members of Congress and 4 other candidates in 2025–26.
See every candidate and member Gilead Sciences gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in